---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Thio Compounds and Thalidomide Analogues for the Treatment of Neurological Diseases"
date: 2026-02-05 19:09:33 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-08560
original_published: 2020-04-23 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Thio Compounds and Thalidomide Analogues for the Treatment of Neurological Diseases

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 23, 2020 00:00 UTC
**Document Number:** 2020-08560

## Summary

The National Institute on Aging and the National Cancer Institute, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the U.S. and foreign Patents and Patent Applications listed in the Supplementary Information section of this notice to AevisBio, Inc. located in 814 W Diamond Ave., Suite 203, Gaithersburg, MD 20870.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/04/23/2020-08560/prospective-grant-of-an-exclusive-patent-license-thio-compounds-and-thalidomide-analogues-for-the)
- API: https://www.federalregister.gov/api/v1/documents/2020-08560

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
